Bicarbonate

Bicarbonate

SCHEMBL3037570

O.O.O.O.O.O.O=C([O-])[O-].[Ca+2]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA4 P22748 5/20 0.46
CA1 P00915 3/20 0.46
FAHD1 Q6P587 1/20 0.46
LMNA P02545 2/20 0.36
MEN1 O00255 1/20 0.36
LDHA P00338 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
CASP1 P29466 1/20 0.33
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL175616 1.00
Bicarbonate SCHEMBL7631660 1.00
Bicarbonate SCHEMBL5680462 1.00
Bicarbonate SCHEMBL28586227 1.00 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL17746828 1.00
Bicarbonate SCHEMBL28043173 1.00 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL3976963 1.00 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL14563714 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL5557766 0.94
Bicarbonate SCHEMBL10788717 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119607491-A Battery fire extinguishing agent and preparation method and application thereof 深圳普瑞赛思检测科技股份有限公司 2025-03-14 CN claimed
WO-2021257757-A1 CARBONATABLE COMPOSITIONS WITH ADMIXTURES SOLIDIA TECHNOLOGIES, INC. (US) 2021-12-23 WO claimed
CN-111892076-A Preparation method for obtaining amorphous calcium carbonate particles with nano-pore structure by organic solvent induction 武汉理工大学 2020-11-06 CN claimed
US-9105780-B2 Method of fabricating graphene quantum dots and high quality graphene quantum dots using the method KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-08-11 US claimed
US-20150118143-A1 METHOD OF FABRICATING GRAPHENE QUANTUM DOTS AND HIGH QUALITY GRAPHENE QUANTUM DOTS USING THE METHOD KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-04-30 US claimed
US-5220875-A Reacting sulfur dioxide with calcined sorbent in presence of oxygen to form solid inorganic sulfate AMERICAN OXYCARB CORPORATION (US) 1993-06-22 US claimed
US-5102701-A Applying a mixture of bromochlorinated paraffin and antimony oxide with an acrylic latex binder WEST POINT PEPERELL (US) 1992-04-07 US claimed
US-20260007643-A1 HIGHLY SOLUBLE FORMULATIONS OF HARMINE RECONNECT LABS AG (CH) 2026-01-08 US disclosed
EP-3918131-B1 A PAPERBOARD AND A METHOD OF PRODUCING A PAPERBOARD STORA ENSO OYJ (FI) 2025-10-22 EP disclosed
EP-3728487-B1 METHOD OF REMOVING POLYMERIC MATERIAL COMPRISING HETEROATOMS FROM A SURFACE USING COMPOSITIONS INCLUDING A KETO-ESTER COMPOUND FOURTH PRINCIPLE LLC (US) 2025-07-02 EP disclosed
EP-4561527-A2 HIGHLY SOLUBLE FORMULATIONS OF HARMINE Reconnect Labs AG (CH) 2025-06-04 EP disclosed
EP-4561573-A1 DEXMEDETOMIDINE FOR THE TREATMENT OF SLEEP DISORDERS Universität Zürich (CH) 2025-06-04 EP disclosed
CN-119968198-A High solubility harmine preparation 莱科奈科特实验室股份公司 2025-05-09 CN disclosed
EP-0113978-A1 Fabric washing process UNILEVER PLC (GB) 1984-07-25 EP disclosed
US-4452909-A USING ALKALI METAL SILICATES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1984-06-05 US disclosed
EP-0106158-A2 Process for coating crystalline silica polymorphs E.I. DU PONT DE NEMOURS AND COMPANY (US) 1984-04-25 EP disclosed
US-4407722-A DELAY OF REACTION BETWEEN SECONDARY BUILDER AND CALCIUM HARDNESS LEVER BROTHERS COMPANY (US) 1983-10-04 US disclosed
EP-0068721-A1 Fabric washing process and detergent composition for use therein UNILEVER N.V. (NL) 1983-01-05 EP disclosed
US-4237147-A CARBONATED BEVERAGE CONCENTRATE, NONTOXIC ACID MONSANTO COMPANY (US) 1980-12-02 US disclosed
US-4137218-A MOLDING MATERIALS ALLIED CHEMICAL CORPORATION (US) 1979-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260007643-A1 HIGHLY SOLUBLE FORMULATIONS OF HARMINE SLC6A2, SLC7A1, DLST CA4 1939/4885CA1 851/4885FAHD1 3490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.